Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
PFE Pfizer Inc. daily Stock Chart
PFE [NYSE]
Pfizer Inc.
Healthcare | Drug Manufacturers - Major | USA
financial highlights | statements
IndexDJIA S&P500 P/E23.71 EPS (ttm)1.81 Insider Own0.10% Shs Outstand5.60B Perf Week0.16%
Market Cap239.69B Forward P/E13.98 EPS next Y3.06 Insider Trans-16.03% Shs Float5.56B Perf Month-1.79%
Income10.67B PEG3.63 EPS next Q0.75 Inst Own74.90% Short Float1.03% Perf Quarter9.85%
Sales53.86B P/S4.45 EPS this Y-11.90% Inst Trans0.04% Short Ratio2.60 Perf Half Y0.68%
Book/sh10.43 P/B4.11 EPS next Y5.30% ROA7.10% Target Price45.75 Perf Year14.61%
Cash/sh2.08 P/C20.63 EPS next 5Y6.53% ROE17.40% 52W Range37.14 - 46.47 Perf YTD-1.90%
Dividend1.44 P/FCF44.11 EPS past 5Y1.00% ROI10.20% 52W High-7.85% Beta0.62
Dividend %3.36% Quick Ratio1.30 Sales past 5Y0.80% Gross Margin79.60% 52W Low15.29% ATR0.64
Employees92400 Current Ratio1.50 Sales Q/Q1.60% Oper. Margin23.30% RSI (14)47.40 Volatility1.11% 1.51%
OptionableYes Debt/Eq0.77 EPS Q/Q14.90% Profit Margin21.30% Rel Volume0.54 Prev Close42.82
ShortableYes LT Debt/Eq0.61 EarningsJul 30 BMO Payout69.60% Avg Volume21.92M Price42.82
Recom2.40 SMA20-1.18% SMA500.42% SMA2000.41% Volume0 Change0.00%
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Jan-31-19Upgrade Argus Hold → Buy
Jan-23-19Downgrade UBS Buy → Neutral
Dec-11-18Downgrade JP Morgan Overweight → Neutral
Nov-01-18Downgrade BMO Capital Markets Outperform → Market Perform
Jun-08-18Initiated Cantor Fitzgerald Overweight $45
Apr-05-18Downgrade Barclays Overweight → Equal Weight $41 → $38
Jan-29-18Reiterated SunTrust Hold $33 → $40
Sep-20-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-20-17Downgrade Credit Suisse Outperform → Neutral
May-16-17Downgrade Citigroup Neutral → Sell
Dec-02-16Initiated Guggenheim Neutral
Nov-02-16Downgrade Argus Buy → Hold
Oct-13-16Downgrade Jefferies Buy → Hold
Jun-20-16Reiterated Jefferies Buy $42 → $40
May-12-16Initiated Berenberg Hold $38
May-04-16Reiterated UBS Buy $36 → $38
Apr-18-16Resumed Goldman Neutral $35
Jul-22-19 05:45PM  Pfizer (PFE) Gains But Lags Market: What You Should Know Zacks
10:55AM  Q2 Earnings Surprise in the Cards, Healthcare ETFs to Buy Zacks
Jul-21-19 01:53PM  Amarin: Is a Buyout Really Off the Table? Motley Fool
09:00AM  Better Buy: Pfizer vs. AbbVie Motley Fool
Jul-20-19 12:07PM  8 More Big Pharma Events in 2019 You Don't Want to Miss Motley Fool
09:00AM  3 Stocks to Build Your Portfolio Around Motley Fool
Jul-19-19 11:36AM  UPDATE 2-Health Canada to keep importing Kaleo's epinephrine shot amid shortages Reuters
11:10AM  Health Canada to keep importing Kaleo's epinephrine shot amid shortages Reuters
Jul-18-19 06:26PM  Allergan Announces FDA Acceptance of Glaucoma Candidate NDA Zacks
Jul-17-19 07:57AM  The Zacks Analyst Blog Highlights: Berkshire Hathaway, Pfizer, Danaher, Tesla and Cintas Zacks
07:43AM  Sarepta vs Pfizer: Which Stock Should Investors Buy? TipRanks
Jul-16-19 06:05PM  Should You Pick Up Novartis (NVS) Before Q2 Earnings? Zacks
05:45PM  Pfizer (PFE) Gains As Market Dips: What You Should Know Zacks
03:05PM  Top Research Reports for Berkshire Hathaway, Pfizer & Danaher Zacks
09:28AM  How Financially Strong Is Pfizer Inc. (NYSE:PFE)? Simply Wall St.
12:00AM  The opioid drugs scandal is depressingly familiar Financial Times
Jul-15-19 04:22PM  Dow Jones Today: China, Earnings Anticipation Stall Stocks on Monday InvestorPlace
06:00AM  Biden healthcare plan would curb drug prices, raise taxes on rich Reuters
Jul-14-19 11:10AM  Health companies start reporting earnings next week: Here are 3 things to keep in mind MarketWatch
Jul-12-19 11:35AM  Drug Pricing Woes Linger on Repealing Drug Rebate Proposal Zacks
11:28AM  AstraZeneca's Imfinzi Gains Orphan Drug Status for SCLC Zacks
11:10AM  Why one top exec at this $105 billion drugmaker is 'very disappointed' with Trump Yahoo Finance
10:23AM  Health Care stocks help lead Wall Street rally Yahoo Finance Video
09:30AM  SNY or PFE: Which Is the Better Value Stock Right Now? Zacks
08:36AM  Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY Zacks
Jul-11-19 05:06PM  US STOCKS-S&P 500, Dow climb as health insurers, financials gain Reuters
04:22PM  Drug distributors surge, drug makers tumble after Trump administration reverses stance on rebates Yahoo Finance
04:05PM  The Dow components that drove the blue-chip stock index to a 27,000 milestone MarketWatch
03:00PM  4 Drug Stocks Getting Smashed InvestorPlace
01:35PM  Drug Stocks Are Falling Because Trumps Next Move on Pricing Could Be Trouble Barrons.com
01:00PM  Here's Why CVS Health Stock Is On the Move Today Motley Fool
09:02AM  Here's Why Sangamo Therapeutics Jumped 23% in June Motley Fool
08:54AM  UPDATE 2-Walgreens expands epinephrine shot partnership as shortage persists Reuters
08:00AM  Pfizer Stock Is The Biggest Pharma But Should You Buy It? Investor's Business Daily
06:19AM  Pfizer Falls 3% Investing.com
05:33AM  Sangamo Up As Gene Therapy Shows Promise in Hemophilia Study (Revised) Zacks
Jul-10-19 05:59PM  US Indexes Close Higher After Dovish Fed Reports GuruFocus.com
05:40PM  Glaxo's Two-Drug HIV Pill Dovato on Par with Three-Drug Pill Zacks
01:16PM  The 10 Biggest Healthcare Stocks Motley Fool
10:14AM  Merck's Keytruda sBLAs for 6-Week Dosing to be Reviewed by FDA Zacks
08:19AM  Here's Why Array BioPharma Soared 75.4% in June Motley Fool
Jul-09-19 05:48PM  Aerie Completes Enrollment Under Rhopressa Study in Japan Zacks
05:45PM  Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know Zacks
11:40AM  Amarin Thinks Sales of Its Cardio Drug Could Be in the Billions GuruFocus.com
11:07AM  Sangamo Up As Gene Therapy Shows Promise in Hemophilia Study Zacks
10:40AM  BioMarin (BMRN) to File for Hemophilia A Candidate in Q4 Zacks
10:06AM  Glaxo's Long-Acting HIV Regimen Gets FDA's Priority Status Zacks
08:00AM  AbbVie Stock Is Poised To Become A Top 5 Pharma But Should You Buy It? Investor's Business Daily
07:41AM  Women Health a Top Priority Now: 3 Stocks to Watch Zacks
Jul-08-19 05:05PM  What Happened in the Stock Market Today Motley Fool
04:18PM  Gene Therapy Battle: Why Sangamo Therapeutics Is Thrashing Its Rivals Investor's Business Daily
03:31PM  Sangamo Therapeutics News: SGMO Stock Surges on Gene Therapy Study InvestorPlace
11:43AM  Pfizer Looks Pretty Smart With Array BioPharma Purchase. Heres Why. Barrons.com
10:07AM  Why Exact Sciences Corporation Stock Gained Nearly 14% in June Motley Fool
Jul-07-19 11:17AM  Better Buy: Pfizer vs. Johnson & Johnson Motley Fool
12:00AM  How private equity overcame its fear of dabbling in drugs Financial Times
Jul-05-19 11:15PM  Sangamo and Pfizer Announce Updated Phase 1/2 Results for SB-525 Investigational Hemophilia A Gene Therapy Showing Sustained Increased Factor VIII Levels Business Wire
08:09PM  The Top 10 Biotechnology Companies (JNJ, ROG.VX) Investopedia
03:21PM  June jobs report crushes expectations as Fed weighs a rate cut Yahoo Finance Video
02:17PM  Why Putting the Former Head of the FDA On Pfizers Board Is So Fraught SAY
09:32AM  Pharma Stock Roundup: PFE's Regulatory/Pipeline Updates, CHMP Nod for Several Drugs Zacks
08:35AM  Dow 30 Stock Roundup: Visa to Buy Verifi, Goldman May Launch Own Cryptocurrency Zacks
Jul-04-19 10:26AM  Glaxo's Dovato Wins EU Nod, RA Candidate Enters Phase III Zacks
Jul-03-19 05:45PM  Pfizer (PFE) Gains But Lags Market: What You Should Know Zacks
10:41AM  Biotech Braces for Busy Summer as 2019 M&A Volume Heats Up Bloomberg
09:34AM  Will the Pharma Space Witness More Mega-Merger Deals in 2H? Zacks
08:44AM  A recession-proof industry you can count on: pet care MarketWatch
08:30AM  Trump's Bully Pulpit Didnt Stop Drug-Price Hikes Bloomberg
07:58AM  3 Big Stock Charts for Wednesday: CVS Health, Pfizer and Weyerhaeuser InvestorPlace
Jul-02-19 04:56PM  Pfizer's Eucrisa Proves Safety in Kids with Atopic Dermatitis Zacks
03:38PM  3 Dow Jones Stocks to Buy for the Second Half InvestorPlace
03:04PM  Ex-FDA Chief Scott Gottlieb Defends Return To Private Sector, Warren Calls For Resignation Benzinga
02:34PM  GSK hikes price of subsidiary Tesaro's ovarian cancer drug American City Business Journals
02:15PM  Senator Warren asks former FDA chief Gottlieb to resign from Pfizer board Reuters
11:32AM  Sen. Elizabeth Warren Urges New Pfizer Board Member Gottlieb to Resign TheStreet.com
11:31AM  CORRECTED-Pfizer, Sanofi, to boost South African Biovac's vaccine output Reuters
09:31AM  Company News for Jul 2, 2019 Zacks
09:09AM  Pfizer, Sanofi, to boost South African Biovac's vaccine output Reuters
09:06AM  GSK-Pfizer JV gets conditional approval from S.Africa's competition regulator Reuters
Jul-01-19 04:21PM  S&P 500 settles below intraday high sparked by U.S.-China trade truce MarketWatch
10:24AM  The Zacks Analyst Blog Highlights: NIKE, Walgreens Boots Alliance, UnitedHealth, Pfizer and Home Depot Zacks
10:11AM  Sarepta Therapeutics Stock Could Capitalize From Pfizers Stumble Barrons.com
10:00AM  Pfizer Completes Acquisition of Therachon Business Wire
09:43AM  Pfizer's (PFE) Avastin Biosimilar Zirabev Gets FDA Approval Zacks
09:42AM  Pfizer Gains on Positive Children-Dermatitis Treatment Results TheStreet.com
09:35AM  Sarepta Up as Pfizer's DMD Gene Therapy Faces Safety Issues Zacks
09:30AM  Company News for Jul 1, 2019 Zacks
09:21AM  Pfizer's DMD Gene Therapy Shows Severe Side Effects in Study Zacks
08:27AM  Pfizer stock up 1.2% premarket after drugmaker announces positive results from Phase 4 eczema study MarketWatch
08:00AM  Pfizer Announces Positive Top-Line Results from Phase 4 Study of Crisaborole Ointment, 2%, in Children Aged 3 Months to Less Than 24 Months with Mild to Moderate Atopic Dermatitis Business Wire
Jun-30-19 12:15PM  Pfizer's About to Enter a Sales Slump -- Here's Why You Should Like the Stock Anyway Motley Fool
Jun-29-19 04:49PM  How Mastercard and Other Hedge Fund Favorites Performed in Q2 Insider Monkey
Jun-28-19 06:07PM  These Are The 5 Worst Dow Jones Stocks In The First Half Of 2019 Investor's Business Daily
05:08PM  AstraZeneca's Imfinzi Meets Endpoint in Lung Cancer Study Zacks
04:28PM  Gene Therapy Battle: Pfizer's Test Results Sent This Biotech Stock Flying Investor's Business Daily
04:27PM  Here's Why Sarepta Therapeutics Is Surging Today Motley Fool
04:05PM  Pfizer Announces Results from Phase 3 Trial of Revatio® (Sildenafil Citrate) in Newborns with Persistent Pulmonary Hypertension Business Wire
01:35PM  Sarepta Therapeutics Soars as Pfizer's Competing Drug Shows Safety Problems TheStreet.com
12:28PM  Street Crowns Sarepta DMD Gene Therapy King After Pfizer Results Bloomberg
10:34AM  Sarepta surges after Pfizer gene therapy data raises safety concerns Reuters
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands. The company also provides consumer healthcare products that comprise over-the-counter medicines, including dietary supplement products under the Centrum, Caltrate, and Emergen-C names; pain management products under the Advil and ThermaCare names; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H names; and respiratory and personal care products under the Robitussin, Advil Cold & Sinus, and ChapStick names. In addition, it offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit, Ixifi Infliximab BS names. Further, the company is also involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Oncolytics Biotech Inc.; licensing agreement with BionTech AG; strategic alliance with Verily Life Sciences LLC; and collaboration agreements with Pfizer, Merck & Co., Inc., and Eli Lilly & Company, as well as with Merck KGaA and Nektar Therapeutics to develop a therapy for treating pancreatic cancer. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAMELIO FRANK AExecutive Vice PresidentJul 02Sale44.09153,1846,753,385337,392Jul 03 04:06 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentJun 20Sale44.0030,0001,320,00080,094Jun 21 04:08 PM
PFIZER INC10% OwnerMay 13Buy17.0050,000850,0003,249,973May 14 07:34 AM
MACKENZIE ALEXANDER RExecutive Vice PresidentApr 01Sale42.8315,000642,503110,094Apr 02 03:05 PM
JOHNSON RADY AExecutive Vice PresidentMar 15Sale41.138,700357,83159,797Mar 18 06:37 PM
READ IAN CExecutive ChairmanMar 04Sale43.2950,7882,198,4741,639,280Mar 06 04:03 PM
READ IAN CExecutive ChairmanMar 04Sale43.17530,07822,882,7021,109,202Mar 06 04:03 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale43.268,725377,444172,094Mar 06 03:29 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale43.1463,9982,760,698108,096Mar 06 03:29 PM
ROGERS DAWNExecutive Vice PresidentMar 04Sale42.9815,002644,79814,920Mar 05 04:55 PM
Dolsten MikaelPresident R&DMar 04Sale43.5249,0822,136,293289,126Mar 05 04:54 PM
Dolsten MikaelPresident R&DMar 01Option Exercise31.34106,1913,328,057438,679Mar 05 04:54 PM
Dolsten MikaelPresident R&DMar 01Sale43.56100,4714,376,852338,208Mar 05 04:54 PM
ROGERS DAWNExecutive Vice PresidentFeb 27Option Exercise32.2319,297621,94245,049Mar 01 07:47 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Option Exercise32.2385,7632,764,141228,743Mar 01 07:47 PM
YOUNG JOHN DGroup PresidentFeb 27Option Exercise32.23154,3744,975,474441,923Mar 01 07:47 PM
GOETTLER MICHAELGroup PresidentFeb 27Option Exercise32.2330,017967,44848,652Mar 01 07:37 PM
Hwang AngelaGroup PresidentFeb 27Option Exercise32.2311,792380,05623,635Mar 01 07:37 PM
JOHNSON RADY AExecutive Vice PresidentFeb 27Option Exercise32.2330,017967,44881,341Mar 01 07:37 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27Option Exercise32.2364,3222,073,098123,145Mar 01 07:37 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 27Option Exercise32.2381,4752,625,939416,278Mar 01 07:37 PM
BOURLA ALBERTChief Executive OfficerFeb 27Option Exercise32.2364,3222,073,098331,982Mar 01 07:29 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 27Option Exercise32.2325,729829,246121,743Mar 01 07:29 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 27Option Exercise32.23182,2475,873,821588,177Mar 01 07:29 PM
YOUNG JOHN DGroup PresidentFeb 23Option Exercise21.0343,724919,516312,403Feb 26 07:45 PM
JOHNSON RADY AExecutive Vice PresidentFeb 23Option Exercise21.0318,004378,62461,182Feb 26 07:45 PM
BOURLA ALBERTChief Executive OfficerFeb 23Option Exercise21.0336,008757,248191,438Feb 26 07:45 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 23Option Exercise21.0387,4491,839,052388,024Feb 26 07:45 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 23Option Exercise21.03185,1853,894,441522,576Feb 26 07:45 PM
SUSMAN SALLYExecutive Vice PresidentFeb 23Option Exercise21.0397,7372,055,409205,833Feb 26 07:46 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 23Option Exercise21.0343,724919,51683,781Feb 26 07:45 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 23Option Exercise21.0341,615875,163144,164Feb 26 07:10 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 23Option Exercise21.0330,864649,070115,139Feb 26 07:10 PM
ROGERS DAWNExecutive Vice PresidentFeb 23Option Exercise21.0319,290405,66937,638Feb 26 07:10 PM
GOETTLER MICHAELGroup PresidentFeb 23Option Exercise21.0319,290405,66931,507Feb 26 07:11 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 01Sale42.755,000213,75040,057Feb 01 07:21 PM
Dolsten MikaelPresident R&DJan 31Option Exercise29.78125,9683,751,425362,051Feb 01 07:28 PM
LANKLER DOUGLAS MExecutive Vice PresidentJan 30Sale41.1938,8001,598,07145,057Feb 01 07:21 PM
READ IAN CChairman & CEONov 02Option Exercise26.641,100,20129,312,5881,760,958Nov 06 03:46 PM
PFIZER INC10% OwnerOct 15Buy18.0055,5561,000,00822,032,040Oct 17 05:17 PM
Dolsten MikaelPresident R&DSep 13Option Exercise24.56181,7124,462,167234,299Sep 17 04:08 PM
OLSON LAURIE JExecutive Vice PresidentAug 13Sale41.0010,214418,77472,672Aug 14 05:04 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentAug 03Sale39.5125,6421,013,171102,412Aug 06 03:19 PM
GOETTLER MICHAELGroup PresidentAug 01Sale39.7019,198762,11611,924Aug 03 03:38 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerAug 01Sale40.1626,8141,076,93383,846Aug 03 03:36 PM
LUND-JURGENSEN KIRSTENExecutive Vice PresidentAug 01Sale40.0420,942838,5724,643Aug 03 03:35 PM
DAMELIO FRANK AExecutive Vice PresidentAug 01Sale40.00150,4846,019,360337,391Aug 03 03:33 PM
open in yahoo | open in reuters | open in google